BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 28081969)

  • 21. Evaluation of two serological methods for potency testing of whole cell pertussis vaccines.
    von Hunolstein C; Gomez Miguel MJ; Pezzella C; Scopetti F; Behr-Gross ME; Halder M; Hoffmann S; Levels L; van der Gun J; Hendriksen C
    Pharmeuropa Bio; 2008 Dec; 2008(1):7-18. PubMed ID: 19220977
    [TBL] [Abstract][Full Text] [Related]  

  • 22. EDQM biological reference preparation for rabies vaccine (inactivated) for veterinary use.
    Daas A; Bruckner L; Milne C
    Pharmeur Bio Sci Notes; 2015; 2015():57-72. PubMed ID: 26830159
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alternatives for potency testing of veterinary vaccines: rabies vaccine as a model.
    Bruckner L; Kihm U
    Dev Biol Stand; 1986; 64():93-7. PubMed ID: 3792660
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Report on the international workshop on alternative methods for human and veterinary rabies vaccine testing: state of the science and planning the way forward.
    Stokes W; McFarland R; Kulpa-Eddy J; Gatewood D; Levis R; Halder M; Pulle G; Kojima H; Casey W; Gaydamaka A; Miller T; Brown K; Lewis C; Chapsal JM; Bruckner L; Gairola S; Kamphuis E; Rupprecht CE; Wunderli P; McElhinney L; De Mattia F; Gamoh K; Hill R; Reed D; Doelling V; Johnson N; Allen D; Rinckel L; Jones B
    Biologicals; 2012 Sep; 40(5):369-81. PubMed ID: 22884673
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fusion Peptide Improves Stability and Bioactivity of Single Chain Antibody against Rabies Virus.
    Xi H; Zhang K; Yin Y; Gu T; Sun Q; Shi L; Zhang R; Jiang C; Kong W; Wu Y
    J Microbiol Biotechnol; 2017 Apr; 27(4):718-724. PubMed ID: 28068664
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of a relative potency test using ELISA for human rabies vaccines.
    Wang Z; Sun Y; Wu X; Carroll DS; Lv W; You L; Ji Y; Shi J; Yan J; Xu G; Meng S
    Biologicals; 2018 Sep; 55():59-62. PubMed ID: 29970288
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic strain modification of a live rabies virus vaccine widely used in Europe for wildlife oral vaccination.
    Cliquet F; Robardet E; Picard Meyer E
    Antiviral Res; 2013 Oct; 100(1):84-9. PubMed ID: 23899697
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potency test to discriminate between differentially over-inactivated rabies vaccines: Agreement between the NIH assay and a G-protein based ELISA.
    Toinon A; Moreno N; Chausse H; Mas E; Nicolai MC; Guinchard F; Jaudinaud I; Guinet-Morlot F; Riou P; Manin C
    Biologicals; 2019 Jul; 60():49-54. PubMed ID: 31105021
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel ELISA for quantification of glycoprotein in human rabies vaccines using a clinically proven virus neutralizing human monoclonal antibody.
    Gairola S; Gautam M; Waghmare S
    Hum Vaccin Immunother; 2020 Aug; 16(8):1857-1865. PubMed ID: 31971485
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Virus neutralizing antibody response in mice and dogs with a bicistronic DNA vaccine encoding rabies virus glycoprotein and canine parvovirus VP2.
    Patial S; Chaturvedi VK; Rai A; Saini M; Chandra R; Saini Y; Gupta PK
    Vaccine; 2007 May; 25(20):4020-8. PubMed ID: 17391817
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potency testing of veterinary rabies vaccines: replacement of challenge by in vitro testing: considerations for development of alternative assays.
    Lewis CE; Fry AM; Hermann JR; Siev D; Dusek DM; Gatewood DM
    Dev Biol (Basel); 2012; 134():29-33. PubMed ID: 22888592
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potency of veterinary rabies vaccines in The Netherlands: a case for continued vigilance.
    Rooijakkers EJ; Nieuwenhuijs JH; Vermeulen AA; van Steenis G; Osterhaus AD
    Vet Q; 1996 Dec; 18(4):146-50. PubMed ID: 8972063
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantitative determination of rabies antigen by ELISA.
    van der Marel P; van Wezel AL
    Dev Biol Stand; 1981; 50():267-75. PubMed ID: 7341294
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A versatile in vitro ELISA test for quantification and quality testing of infectious, inactivated and formulated rabies virus used in veterinary monovalent or combination vaccine.
    Sigoillot-Claude C; Battaglio M; Fiorucci M; Gillet D; Vimort AS; Giraud Y; Laurent S; Vaganay A; Poulet H
    Vaccine; 2015 Jul; 33(32):3843-9. PubMed ID: 26144898
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Establishment of a potency test by ELISA for a rabies vaccine for animal use in Japan.
    Gamoh K; Shimazaki Y; Senda M; Makie H; Itoh O; Muramatsu M; Hirayama N; Hatakeyama H
    J Vet Med Sci; 2003 Jun; 65(6):685-8. PubMed ID: 12867727
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multicenter comparative study of a new ELISA, PLATELIA RABIES II, for the detection and titration of anti-rabies glycoprotein antibodies and comparison with the rapid fluorescent focus inhibition test (RFFIT) on human samples from vaccinated and non-vaccinated people.
    Feyssaguet M; Dacheux L; Audry L; Compoint A; Morize JL; Blanchard I; Bourhy H
    Vaccine; 2007 Mar; 25(12):2244-51. PubMed ID: 17224214
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Collaborative study for validation of a serological potency assay for rabies vaccine (inactivated) for veterinary use.
    Krämer B; Bruckner L; Daas A; Milne C
    Pharmeur Bio Sci Notes; 2010 Oct; 2010(2):37-55. PubMed ID: 21144488
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Collaborative study for the validation of cell line assays for in-process toxicity and antigenicity testing of Clostridium septicum vaccine antigens - Part 2: Optimisation of cell line assays.
    Behr-Gross ME; Siklodi B; Le Tallec D; Halder M; Manou I; Sinitskaya N; Bruckner L; Dalmadi B; Kiss L; Redhead K
    Pharmeur Bio Sci Notes; 2021; 2021():101-156. PubMed ID: 34078535
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Establishment of batch 4 of the Biological Reference Preparation (BRP) for rabies vaccine (inactivated) for veterinary use.
    Daas A; Milne C
    Pharmeuropa Bio; 2004 Dec; 2004(1):17-22. PubMed ID: 15659282
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Validation of a new ELISA method for in vitro potency testing of hepatitis A vaccines.
    Morgeaux S; Variot P; Daas A; Costanzo A
    Pharmeur Bio Sci Notes; 2013; 2013():64-92. PubMed ID: 24447723
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.